Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy (Cancer Sensitizing Agents for Chemotherapy Book 4) (Volume 4)
4.3 (137 items)
Limited Time SaleUS$86.96 cheaper than the new price!!
Free cash-on-delivery fees for purchases over $99
Product details
| Management number | 233567192 | Release Date | 2026/06/27 | List Price | US$57.98 | Model Number | 233567192 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.- Summarizes the sensitizing role of some tyrosine kinase inhibitors in existing research- Brings recent findings in several cancer types, both experimental and clinically, with a particular emphases on underlying biochemical, genetic, and molecular mechanisms- Provides an updated and comprehensive knowledge regarding the field of combinational cancer treatment Read more
Bestseller ranking
Nail Fungus Treatments
Customers who viewed this product also viewed
Molecular Biology
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form